Vencio S, Caiado-Vencio R, Caixeta LF, Masierek M, et al. A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication. Diabetes Obes Metab 2022 Apr 19. doi: 10.1111/dom.14724.
PMID: 35441466